首页 正文

Evolving roles of systemic therapy in hepatocellular carcinoma: neoadjuvant and adjuvant strategies

{{output}}
Surgical resection for early-stage hepatocellular carcinoma (HCC) provides the potential for long-term survival but recurrence rates within 5 years were up to 70%. Thus, neoadjuvant or adjuvant strategies can be important to improve outcomes. Previous efforts ... ...